The Case for Brachytherapy: Why It Deserves a Renaissance.

The Case for Brachytherapy: Why It Deserves a Renaissance.
复制标题

DOI:
10.1016/j.adro.2020.10.018
复制
发表时间:
2021-03
影响因子:
2.3
通讯作者:
Dyer BA
Dyer BA
中科院分区:
其他
文献类型:
--
作者:
Williams VM;Kahn JM;Thaker NG;Beriwal S;Nguyen PL;Arthur D;Petereit D;Dyer BA

文献摘要

参考文献

被引文献

相似文献

最近与2019年冠状病毒病大流行相关的全球事件显着改变了医疗格局,并导致肿瘤学治疗视角的转变。在保持医疗可及性和减少医疗资源利用的同时,重新将重点放在保存治疗结果上。近距离放射治疗是许多癌症(特别是前列腺癌和妇科癌症)治疗过程中至关重要的一部分,它能够提供低分割辐射,从而缩短治疗时间。21世纪初的研究表明,尽管有数据显示,在前列腺和宫颈等疾病部位,近距离放射治疗的治疗效果相当,甚至更好,但近距离放射治疗的使用量有所下降。然而,较新的数据表明,这一趋势可能正在逆转。根据显示同等结果的数据,再次呼吁缩短放射疗程,可能会将低分割辐射确立为多个疾病地点的护理标准。随着报销方式的变化,近距离放射治疗代表了低分割、适形放射治疗的顶峰,并有大量长期数据支持这种治疗模式,近距离放射治疗即将迎来复兴。
The recent global events related to the coronavirus disease of 2019 pandemic have significantly changed the medical landscape and led to a shift in oncologic treatment perspectives. There is a renewed focus on preserving treatment outcomes while maintaining medical accessibility and decreasing medical resource utilization. Brachytherapy, which is a vital part of the treatment course of many cancers (particularly prostate and gynecologic cancers), has the ability to deliver hypofractionated radiation and thus shorten treatment time. Studies in the early 2000s demonstrated a decline in brachytherapy usage despite data showing equivalent or even superior treatment outcomes for brachytherapy in disease sites, such as the prostate and cervix. However, newer data suggest that this trend may be reversing. The renewed call for shorter radiation courses based on data showing equivalent outcomes will likely establish hypofractionated radiation as the standard of care across multiple disease sites. With shifting reimbursement, brachytherapy represents the pinnacle in hypofractionated, conformal radiation therapy, and with extensive long-term data in support of the treatment modality brachytherapy is primed for a renaissance.
DOI: 10.7326/0003-4819-158-12-201306180-00002
发表时间: 2013-06-18
影响因子: 39.2
作者:
Hayes, Julia H.;Ollendorf, Daniel A.;McMahon, Pamela M.
通讯作者: McMahon, Pamela M.
DOI: 10.1016/j.brachy.2019.02.008
发表时间: 2019-07-01
期刊: BRACHYTHERAPY
影响因子: 1.9
作者:
Albuquerque, Kevin;Hrycushko, Brian A.;Yashar, Catherine
通讯作者: Yashar, Catherine
DOI: 10.1016/j.radonc.2012.04.007
发表时间: 2012-06-01
影响因子: 5.7
作者:
Charra-Brunaud, Claire;Harter, Valentin;Peiffert, Didier
通讯作者: Peiffert, Didier
DOI: 10.1016/j.brachy.2016.09.011
发表时间: 2017-01-01
期刊: BRACHYTHERAPY
影响因子: 1.9
作者:
Karlsson, Johannes;Dreifaldt, Ann-Charlotte;Sorbe, Bengt
通讯作者: Sorbe, Bengt
DOI: 10.1111/j.1464-410x.2009.08445.x
发表时间: 2009-09-01
期刊: BJU INTERNATIONAL
影响因子: 4.5
作者:
Aaronson, David S.;Yamasaki, Ichiro;Shinohara, Katsuto
通讯作者: Shinohara, Katsuto